Systemic Lupus Erthematosus (SLE)Nutrition and dietMicrobiomeSupplementsDietary supplement
What this study is
To study the effect of anti-inflammatory diet on clinical and biological outcomes in lupus
What's being tested
- anti-inflammatory diet
Intervention · DIETARY SUPPLEMENT
anti-inflammatory diet for 6 weeks
Study details
- Sponsor
- University of California, San Diego
- Conditions
- Systemic Lupus Erthematosus (SLE)
- Enrolling
- 36 people
- Starts
- 2026-07-01
- Est. completion
- 2029-07-01
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients who meet the 2019 EULAR/ACR Classification Criteria for SLE
- Patients who are on Cellcept or Myfortic for at least 3 months prior to screening
- Patients with a score of ≥55 on the Patient Reported Outcomes Measurement Information System (PROMIS) Pain interference scale.
You can't join if
- Pregnant or lactating patients,
- Patients with food allergy
- Patients on antibiotics within 4 weeks of the screening
- Patients that change the SLE therapy during the length of the study (12 weeks).
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openAltman Clinical Translational Research Insitute (UC San Diego)
La Jolla, California, United States
- Monica Guma, MD, PhD · Contact858-mguma@health.ucsd.edu
- Monica Guma, MD.PhD · Principal investigator
Recruiting
Study team
Sponsor
University of California, San Diego
Study ID 161474_3
Principal investigator
Monica Guma, MD, PhD
UC San Diego
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.